
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Founded in 2006 and acquired by ZOLL in 2021, ZOLL Respicardia is a leader in innovative technologies that address the unmet needs of people with Central Sleep Apnea (CSA). CSA results from the brains inability to send appropriate signals to the respiratory muscles to stimulate breathing during sleep. CSA is a serious breathing disorder that disrupts the normal breathing pattern and negatively affects quality of life and overall health. The remede System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for people with CSA
Zoll respicardia operates in the Medical equipment manufacturing industry.
Zoll respicardia's revenue is 11m - 100m
Zoll respicardia has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.